Another study showed that inhibiting HIF-1α in adipose tissue can alleviate obesity and insulin resistance, making HIF-1α a potential therapeutic target for obesity and T2DM. The gene discussed is HIF1A; the disease is obesity due to melanocortin 4 receptor deficiency.